NewAmsterdam Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:KH6 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Nov 24	Sell€555,972	Forbion Capital Partners B.V.	Company	23,443	€23.73
14 Nov 24	Sell€246,516	Forbion Capital Partners B.V.	Company	10,430	€23.64
26 Sep 24	Buy€15,508	Juliette Audet	Individual	1,104	€14.05
20 Aug 24	Buy€73,272	Michael Davidson	Individual	5,000	€14.65
20 Jun 24	Buy€80,543	Michael Davidson	Individual	5,000	€16.11
26 Mar 24	Buy€167,396	Frazier Life Sciences Management, LP	Company	8,429	€19.86
13 Feb 24	Buy€88,626	Louis Lange	Individual	5,000	€17.73

Insider Trading Volume

Insider Buying: KH6 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KH6?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,103,426	1.19%
Private Companies	2,500,707	2.71%
General Public	6,480,624	7.01%
Hedge Funds	8,024,565	8.69%
Institutions	31,104,683	33.7%
VC/PE Firms	43,171,867	46.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.2%.

Top Shareholders

Top 25 shareholders own 85.36% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.9%	Frazier Life Sciences Management, LP	12,855,194	€248.4m	5.14%	12.3%
12.8%	Forbion Capital Partners B.V.	11,778,760	€227.6m	-0.45%	43.95%
11.3%	Bain Capital Life Sciences Investors, LLC	10,473,913	€202.4m	0%	24.66%
8.73%	RA Capital Management, L.P.	8,064,000	€155.8m	0%	2.33%
8.69%	Viking Global Investors LP	8,024,565	€155.0m	0%	0.65%
4.4%	The Morningside Group Limited	4,060,923	€78.5m	0%	20.0%
3.11%	Medicxi Ventures (UK) LLP	2,869,565	€55.4m	0%	13.56%
2.7%	Forbion International Management B.V.	2,498,438	€48.3m	0%	no data
2.67%	Cormorant Asset Management, LP	2,470,000	€47.7m	7.39%	2.82%
1.67%	Janus Henderson Group plc	1,540,729	€29.8m	51.1%	0.01%
1.65%	BVF Partners L.P.	1,521,948	€29.4m	0%	1.08%
1.63%	Polar Capital Holdings Plc	1,505,000	€29.1m	50.1%	0.13%
1.49%	Adage Capital Management, L.P.	1,380,000	€26.7m	-9.8%	0.06%
1.26%	Woodline Partners LP	1,164,677	€22.5m	141%	0.23%
1.1%	Jennison Associates LLC	1,020,278	€19.7m	8.87%	0.01%
1.1%	Pictet Asset Management Limited	1,016,847	€19.6m	48.7%	0.02%
1%	The Invus Group, LLC	920,564	€17.8m	0%	1.04%
0.98%	Deerfield Management Company, L.P. Series C	901,750	€17.4m	3.74%	0.36%
0.96%	Avidity Partners Management, L.P.	889,700	€17.2m	59.1%	1.17%
0.9%	GMT Capital Corp.	829,036	€16.0m	-7.04%	0.59%
0.89%	Michael Davidson	818,563	€15.8m	0.61%	no data
0.73%	Medical Strategy GmbH, Asset Management Arm	671,177	€13.0m	0%	0.97%
0.64%	Decheng Capital LLC	590,000	€11.4m	47.5%	3.02%
0.57%	Citadel Advisors LLC	522,465	€10.1m	144%	0.01%
0.51%	Affinity Asset Advisors, LLC	472,390	€9.1m	11.6%	1.92%